空军医学杂志
空軍醫學雜誌
공군의학잡지
MEDICAL JOURNAL OF AIR FORCE
2014年
2期
105-107
,共3页
肖黎%关小宏%吴石白%杨彩哲%李娟
肖黎%關小宏%吳石白%楊綵哲%李娟
초려%관소굉%오석백%양채철%리연
2型糖尿病%控制%达标率
2型糖尿病%控製%達標率
2형당뇨병%공제%체표솔
Type 2 diabetes%Control%Compliance rate
目的:评价目前空军驻京部队干部2型糖尿病患者血糖、血压、血脂综合控制现状。方法选择已确诊为2型糖尿病486例作为调查对象,参照2010年《中国2型糖尿病防治指南》推荐标准,评价其血糖、血压、血脂的控制水平。结果糖化血红蛋白(HbA1c)控制理想、良好、差率分别为52.7%、12.5%、34.8%,血压(BP)、低密度脂蛋白(LDL-C)控制理想率分别为53.8%、32.5%。结论空军驻京部队干部2型糖尿病控制水平优于或不低于国内、国外及北京市城区糖尿病控制水平。提示空军分层保障医疗体系对2型糖尿病控制有明显优势,但在对个性化管理方面等仍需进一步加强。
目的:評價目前空軍駐京部隊榦部2型糖尿病患者血糖、血壓、血脂綜閤控製現狀。方法選擇已確診為2型糖尿病486例作為調查對象,參照2010年《中國2型糖尿病防治指南》推薦標準,評價其血糖、血壓、血脂的控製水平。結果糖化血紅蛋白(HbA1c)控製理想、良好、差率分彆為52.7%、12.5%、34.8%,血壓(BP)、低密度脂蛋白(LDL-C)控製理想率分彆為53.8%、32.5%。結論空軍駐京部隊榦部2型糖尿病控製水平優于或不低于國內、國外及北京市城區糖尿病控製水平。提示空軍分層保障醫療體繫對2型糖尿病控製有明顯優勢,但在對箇性化管理方麵等仍需進一步加彊。
목적:평개목전공군주경부대간부2형당뇨병환자혈당、혈압、혈지종합공제현상。방법선택이학진위2형당뇨병486례작위조사대상,삼조2010년《중국2형당뇨병방치지남》추천표준,평개기혈당、혈압、혈지적공제수평。결과당화혈홍단백(HbA1c)공제이상、량호、차솔분별위52.7%、12.5%、34.8%,혈압(BP)、저밀도지단백(LDL-C)공제이상솔분별위53.8%、32.5%。결론공군주경부대간부2형당뇨병공제수평우우혹불저우국내、국외급북경시성구당뇨병공제수평。제시공군분층보장의료체계대2형당뇨병공제유명현우세,단재대개성화관리방면등잉수진일보가강。
Objective To evaluate the current blood sugar, blood pressure, blood lipid control of the Beijing Air Force garrison troops cadres with type 2 diabetes. Methods Randomly selected 486 patients diagnosed as type 2 diabetes as the objects of the investigation. With reference to the Chinese Type 2 Diabetes Prevention Guide in 2010, we evaluated the level of control of their blood sugar, blood pressure and blood lipids. Results The ratio of glycated hemoglobin ideal control, good control and poor control were 52.7%,12.5% and 34.8% respectively. The ratio of ideal control of blood pressure and low-density lipoprotein were 53.8% and 32.5%. Conclusions The diabetic control level of the Air Force garrison troops cadres is better than or not worse than the overall domestic level, foreign level and diabetes control level in Beijing. It prompts that the Air Force layered security health system shows an obvious advantage on the control of type 2 diabetes, but we need to strengthen the individual management for patients.